Hellen De Kloet, Biz Head-Western Europe & ANZ, Sun Pharma said the launch of ‘Gemcitabine InfuSMART‘ will start in the UK and the Netherlands because these are the first two countries in Europe where we have final approval.
first published: Jul 11, 2016 01:24 pm
A collection of the most-viewed Moneycontrol videos.
Live: Nifty holds above 25,900 but off nearly 100 pts from day's high | Closing Bell
Live: Will Nifty reclaim 26,000-mark amid record low inflation in Oct? | Opening Bell
Live: Nifty extends gain to third day, above 25,850 amid broad-based buying | Closing Bell
Live: Can Nifty approach 25,800-mark and extend gains to third day? | Opening Bell
